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CLINICAL INVESTIGATIONS 
Dynamic QRS complex and ST segment 
vectorcardiographic monitoring can identify 
vessel patency in patients with acute 
myocardial infarction treated with reperfusion 
therapy 
Reperfusion therapy has lowered the mortality in patients suffering acute myocardial infarction. 
Failure to reperfuse is associated with significantly higher risk of short- and long-term mortality. 
Detection of reperfusion is thus important. In a prospective pilot study, we used continuous 
on-line computerized vectorcardiography to monitor 21 patients with acute myocardial infarction 
treated with reperfusion therapy to noninvasively detect coronary patency. By using trend 
analysis of QRS vector difference, we were able to correctly blindly identify 15 of 16 patients 
with a perfused infarct-related artery and four of six patients with a persistently occluded artery 
at an early angiogram. The present results are based on a limited number of patients, but 
suggest that QRS complex and ST segment monitoring with continuous on-line 
vectorcardiography has substantial potential for monitoring patients with acute myocardial 
infarction treated with reperfusion therapy. (AM HEART J 1991;122:943.) 
Mikael Dellborg, MD, Eric J. Topol, MD,a and Karl Swedberg, MD. 
Giiteborg, Sweden, and Ann Arbor, Mich. 
Reperfusion therapy has lowered the mortality in 
patients suffering acute myocardial infarction.lm3 The 
beneficial effect seems related to reperfusion of the 
ischemic myocardium. Accordingly, failure to reper- 
fuse is associated with significantly higher risk of 
short- and long-term mortality.4-7 Early therapeutic 
interventions such as rescue angioplasty after failed 
thrombolytic therapy may be targeted to these pa- 
tients. Detection of reperfusion is thus important. In 
a previous double-blind study of recombinant tissue 
plasminogen activator (rt-PA) versus placebo in 
From the Department of Medicine, &tra Hospital, University of Gdteborg; 
and BDepartment of Medicine, University of Michigan. 
Supported by a grant from AFA, the Labour Market Insurance Company, 
Stockholm, Sweden. 
Received for publication Sept. 4, 1990; accepted May 5, 1991. 
Reprint requests: Mikael Dellborg, MD, Department of Medicine, &&a 
Hospital, University of Giiteborg, 416 85 Giiteborg, Sweden. 
4/l/31114 
acute myocardial infarction,8 we used continuous 
vectorcardiography to monitor infarct development. 
A specific pattern of rapid QRS vector development 
was observed among 37% of patients treated with 
rt-PA versus a 4% incidence in the placebo group.* 
The present report discloses the findings from a pro- 
spective pilot study to evaluate the use of continuous 
on-line computed vectorcardiography to noninva- 
sively detect coronary patency after reperfusion 
therapy for acute myocardial infarction. 
METHODS 
Continuous on-line vectorcardiography. The method 
has been described in detail elsewhere.g We used a com- 
puterized system, the MIDA-system (MIDA 1000, Ortivus 
Medical, T&by, Sweden) for on-line dynamic analysis of 
QRS complex and ST segment changes. In short, with the 
use of eight electrodes placed according to the method of 
Frank,‘O the three orthogonal leads X, Y, and Z are contin- 
uously monitored and analyzed. The signals are averaged 
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Fig. 1. Upper panel shows a trend curve with time on the 
horizontal axis and QRS vector difference and ST vector 
magnitude on the vertical axis. A trend curve from a pa- 
tient with an acute myocardial infarction is illustrated, 
with a slow evolution of electrocardiographic changes. The 
reference mean QRS complex and current mean QRS com- 
plex are shown plotted above each other. The hatched area 
(Ax, Ay, AZ) is the QRS vector difference in lead X, Y, and 
Z, respectively, added according to the formula to form the 
total QRS vector difference. Lower panel, Arrows indicate 
the deviation from baseline of the ST segment 20 msec af- 
ter the termination of the QRS complex in each of the three 
leads- termed Xi, Yi, and Zi. These terms added accord- 
ing to the formula constitute the ST vector magnitude, il- 
lustrated by the initial ST vector magnitude on the trend 
curve above. QRS- VD, QRS vector difference; ST- VM, ST 
vector magnitude. 
over Z-minute periods to form mean vectorcardiagraphic 
complexes. All calculations are done in real time and the 
result is presented on a computer screen. In every individ- 
ual patient changes are related to the initial 2-minute mean 
complex for that patient. The results are presented as con- 
tinuously updated trend curves on the computer screen. 
The two vectorcardiographic parameters studied were 
QRS vector difference and ST vector magnitude (Fig. 1). 
The QRS vector difference can be described as the total 
change within the QRS complex and the ST vector magni- 
tude is the deviation of the ST segment 20 msec after ter- 
mination of the QRS complex, measured and added in all 
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Fig. 2. Pharmacologic reperfusion. Print-out directly 
from the computer screen of a trend curve showing changes 
in the ST vector magnitude and in the QRS vector differ- 
ence over time. The patient has an acute inferior myocar- 
dial infarction. Acute coronary angiography was performed 
after 25 minutes of vectorcardiographic monitoring and 
showed TIM1 grade 3 flaw of the right coronary artery. Ar- 
row indicates first injection of contrast medium. 
the MIDA-system was completely handled by the attend- 
ing research nurse in the coronary catheterization labora- 
tory. 
Patient series. Patients with suspected acute myocar- 
dial infarction were eligible for inclusion if they were 
treated with thrombolytic drugs and/or angioplasty. Rou- 
tine emergency catheterization was performed on all such 
patients and emergency angioplasty was performed if the 
infarct-related artery was found to be occluded. Angio- 
plasty was performed if the patient had a remaining severe 
stenosis of the infarct-related artery. At least 15 minutes of 
vectorcardiographic monitoring preceded acute angiogra- 
phy that had to be performed within 5 hours of the onset 
of chest pain. 
There were 24 patients monitored, 21 of whom on final 
analysis fulfilled the inclusion criteria (three patients were 
excluded because of vectorcardiographic monitoring <15 
minutes before angiography). Fifteen of these 21 patients 
were treated with intravenous urokinase or rt-PA; another 
four patients had an occluded infarct-related artery after 
thrombolysis and were subsequently treated with angio- 
plasty; two patients had emergency angioplasty alone. 
Trial procedure. All patients were treated at the Uni- 
versity of Michigan Medical Center. Patients eligible for 
inclusion were monitored by continuous vectorcar- 
diography for the initial 8 hours. In some cases monitoring 
was terminated prematurely, but it was always conducted 
for at least 15 minutes before catheterization and through- 
out the catheterization procedure. The vectorcardiographic 
recording was stored on floppy disks and was sent to Giite- 
borg for analysis. A simple form with the name, sex, and age 
of the patient and with the times of onset of symptoms, 
initiation of therapy, first injection of contrast material, 
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Fig. 3. Persistent occlusion. Print-out directly from the Fig. 4. Persistent occlusion. Print-out directly from the 
computer screen of a trend curve showing changes in the ST computer screen of a trend curve showing changes in the ST 
vector magnitude and in the QRS vector difference over vector magnitude and in the QRS vector difference over 
time. The patient has a persistent occlusion of the left time. The patient has a persistent occlusion of the left cir- 
circumflex artery despite thrombolysis and attempted an- cumflex artery at angiography after 20 minutes of vector- 
gioplasty. QRS vector difference is slowly increasing, indi- cardiographic monitoring (arrow). The patients fulfills the 
cating a continuously but slowly evolving myocardial in- objective criteria for vectorcardiographic perfusion at the 
farction. The patient was transferred to acute coronary time of angiography. During the following 12 hours the 
bypass surgery after 2 hours of monitoring. Arrow indicates QRS vector difference slowly increases, indicating a slowly 
first injection of contrast medium. developing myocardial infarction. 
and, if performed, angioplasty, accompanied the floppy 
disks. Information regarding coronary anatomy or clinical 
information such as electrocardiographic changes was not 
available to the interpreter of the vectorcardiograms. 
Vectorcardiographic criteria for determining perfu- 
sion and occlusion. Prospective criteria for the develop- 
ment of QRS and ST vector changes were set up. These 
criteria were derived from a previous studye in which we 
observed a pattern of rapid evolution of the QRS vector 
difference associated with rapid relief of chest pain, rapid 
decline of the elevated ST vector magnitude, and low 
in-hospital and l-year mortality compared with patients 
without this rapid pattern. The rapid pattern was defined 
as a rapid evolution of the QRS vector difference, reaching 
a plateau within 2 hours from the start of thrombolytic 
treatment and the start of monitoring, with a concomitant 
but otherwise unspecified decline of the ST vector magni- 
tude. The rapid pattern was highly associated with treat- 
ment with rt-PA and we therefore interpreted this finding 
as possibly caused by rapid coronary reperfusion. The 
mean rate of QRS vector difference evolution was 0.27 /IV/ 
min and the mean rate of ST vector magnitude decline was 
2.0pVlmin in patients with the “rapid pattern,“versus 0.14 
pV/min and 1.0 pV/min for patients with a slow evolution 
of the QRS vector difference. In the present trial, perfusion, 
defined as a Thrombolysis In Myocardial Infarction 
(TIMI) grade flow ~2 of the infarct-related artery at the 
first injection of contrast medium, was tentatively identi- 
fied by an increase of the QRS vector difference by ~0.10 
pV/min from the start of vectorcardiographic monitoring 
until the first injection of contrast medium. A decrease of 
the ST vector magnitude of >0.83 KVlmin was tentatively 
defined as TIM1 grade flow ~2. A subjective evaluation and 
“eye-balling” of each trend curve was also part of the pro- 
tocol. This subjective evaluation also took into consider- 
ation the time to the QRS vector difference evolution pla- 
teau and the subsequent evolution of both the QRS vector 
difference and the ST vector magnitude. Data from both 
the “objective” and the “subjective” evaluation of the 
trend curves were analyzed and were related to the angio- 
graphic changes. 
RESULTS 
Of the 21 patients included, 16 had a patent 
infarct-related artery at the time of the angiography 
and five had a persistent occlusion. Applying the 
prospective criteria for QRS vector difference evolu- 
tion would correctly classify 15 of these 16 vessels as 
patent and would correctly classify two of the five 
persistently occluded arteries. In Fig. 2 the trend 
curves from a patient with pharmacologically in- 
duced perfusion are shown, and in Fig. 3 an example 
of a patient with a persistent occlusion is shown. In 
both cases total agreement was found between the 
objective criteria, the subjective evaluation, and the 
angiogram. The subjective blind evaluation of the 
QRS vector difference trend curve could correctly 
identify 15 of 16 patients with a patent coronary ar- 
tery and four of five patients with persistent occlu- 
sion (sensitivity, 94 7% ; specificity, 80 5% ; positive pre- 
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Fig. 5. Thrombolytic failure-mechanical reperfusion. 
Print-out directly from the computer screen of a trend 
curve showing the change over time in the QRS vector dif- 
ference (QRS-VD) and ST vector magnitude (ST-VM) of 
a patient with acute myocardial infarction. The first arrow 
from left indicates the first angiogram, which revealed an 
occluded left circumflex coronary artery despite previous 
treatment with intravenous urokinase. Limited perfusion 
was established with the guide wire (TIM1 grade 1 flow) 
and subsequently improved to TIM1 grade 3 flow by 
angioplasty (second arrow from left). The patient then had 
an episode of coronary spasm treated by intracoronary ni- 
troglycerin (third arrow from left). Approximately 50 
minutes after the reestablishment of coronary patency, the 
QRS changes reached a plateau, indicating the end of elec- 
trocardiographic change. Vectorcardiographic signs of 
reperfusion are the rapid development of QRS vector dif- 
ference change with an early plateau and the rapid decline 
of the ST vector magnitude. 
dictive value for vectorcardiographic perfusion, 94 % ; 
positive predictive value for vectorcardiographic oc- 
clusion, 80% ). 
In 17 of the 21 patients there was complete agree- 
ment between the two vectorcardiographic evalua- 
tions. In two cases the objective criteria classified the 
patients as having an open infarct-related artery 
whereas both the subjective vectorcardiographic eval- 
uation and the angiogram classified the artery as be- 
ing closed. One of these patients is shown in Fig. 4. 
In one case the objective criteria and the angiogram 
defined the artery as open, in contrast to the result 
from the subjective evaluation, and in one case the 
angiogram defined the artery as closed when the 
objective and subjective evaluation agreed it was 
open. ST vector changes were found to be less in- 
formative, mostly due to the fact that six pa- 
tients showed no changes in the ST vector mag- 
nitude trend curve throughout the monitoring per- 
iod. 
In Fig. 5 a patient with an occluded left circumflex 
coronary artery at the first contrast medium injection 
(first arrow from the left) is shown. Perfusion was 
established with the guide wire (second arrow from 
the left) and an angioplasty was performed, resulting 
in TIM1 grade 3 flow. Recurrent ischemia caused by 
coronary spasm was successfully treated with intra- 
coronary nitroglycerin (third arrow from the left). 
After establishing TIM1 grade 3 flow, a rapid change 
of the QRS and ST vector trend curves occurred, and 
within 45 minutes of reperfusion the QRS vector dif- 
ference and the ST vector magnitude trend curves 
reached a stable plateau, indicating the end of elec- 
trocardiographic change (fourth arrow from the left). 
DISCUSSION 
In the present study coronary perfusion was asso- 
ciated with a rapidly evolving QRS vector difference. 
By using trend analysis of QRS vector difference, we 
were also able to correctly blindly identify 15 of 16 
patients with a perfused infarct-related artery and 
four of five patients with a persistently occluded ar- 
tery at an early angiogram. ST vector magnitude 
changes in the present study were less informative, 
mostly because 6 of 21 patients showed no ST vector 
magnitude changes throughout the monitoring pe- 
riod. 
There have been several attempts to establish a 
method for the noninvasive detection of reperfusion. 
The triad of rapid relief of chest pain, ST segment 
normalization, and the appearance of an idioventric- 
ular rhythm has been shown to predict reperfusion 
with high diagnostic specificity but with too low sen- 
sitivity to be of practical clinical value.‘ls l2 Enzy- 
matic methods may detect reperfusion with high 
accuracy, but their ability to detect ischemia or 
intermittent brief episodes of coronary perfusion is 
limited.13-l” Despite recent advances, they do not 
have true real-time capacity. 
ST segment trend analysis of a continuous three- 
lead electrocardiogram (ECG) has shown high diag- 
nostic accuracy in the clinical setting,16 but offers no 
information on the development of necrosis. The 
conventional l&lead ECG has low sensitivity for de- 
tecting lateral and posterior ischemia,17 but the use 
of the digitized summated 12-lead ECG ST trend was 
recently reported to yield high diagnostic accuracy 
for the noninvasive detection of reperfusion.18 In an- 
imal studies of coronary occlusion/reperfusion, the 
QRS vector difference has been shown to reflect pro- 
gression of myocardial necrosis as well as myocardial 
ischemia.lg There are several reports20, 21 describing 
changes in the QRS complex in up to 90% of all cor- 
onary occlusions during coronary angioplasty. 
In a double-blind, placebo-controlled study with 
rt-PA in patients with suspected acute myocardial 
infarction, we found the QRS vector difference evo- 
lution to be significantly more rapid in patients 
treated with rt-PA.s Inclusion criteria were chest 
pain of less than 2 hours and 45 minutes’ duration 
Volume 122 
Number 4, Part 1 
with or without changes in the resting 12-lead ECG. 
Only 75% of the patients had any ST elevation on a 
standard 12-lead ECG. We were able to blindly iden- 
tity among patients with a final diagnosis of acute myo- 
cardial infarction a pattern of very rapidly developing 
QRS vector difference. This pattern was found in 37 % 
of the patients in the rt-PA group compared with 4% 
in the placebo group. In light of the present finding 
that a high rate of evolution of QRS vector difference 
is associated with perfusion, the rapid pattern of this 
evolution is interpreted as a sign of rapidly restored 
coronary perfusion. Taking only patients with ST 
segment elevation into consideration, the rapid pat- 
tern was thus observed in 50 % of the patients treated 
with rt-PA and in 5% in the placebo group. A 
reperfusion rate of 50% within 2 hours from the start 
of treatment with rt-PA is somewhat low, but within 
the range previously reported, and a spontaneous rate 
of 5% within 2 hours also seems reasonable. 
One possible explanation for the lack of ST vector 
magnitude change in 30% of our patients is the rel- 
atively late start of monitoring in the present study. 
We have previously found that in patients with acute 
myocardial infarction treated with intravenous strep- 
tokinase or rt-PA, the ST vector magnitude returned 
to baseline a mean of 15 minutes before complete ev- 
olution of the QRS vector difference had occurred.8l g 
In the absence of thrombolytic treatment, the ST 
vector magnitude returns to baseline 1 hour and 20 
minutes before the evolution of the QRS vector dif- 
ference is completed. In the present study many pa- 
tients were referred from other hospitals and had 
thus been under treatment with thrombolytic agents 
for some time before vectorcardiographic monitoring 
was started. Thus trend analysis of the QRS vector 
difference may expand the time window for ECG 
analysis of the dynamic process of development of 
myocardial ischemia and necrosis, especially if throm- 
bolysis is not used (or if it is unsuccessful). 
Failed thrombolysis is associated with a compara- 
tively high short- and long-term mortality.4-7 If these 
patients can be accurately identified, therapeutic in- 
terventions such as rescue angioplasty can be tar- 
geted to this subset of patients. In patients with suc- 
cessful thrombolysis with early reestablishment of 
coronary flow, a strategy of “watchful waiting” has 
been advocated.22 Recurrent ischemic events after 
thrombolytic therapy are relatively frequent and oc- 
cur in 12% to 20% of such patients, in most cases 
within the first 72 hours after therapy and often in 
the absence of symptoms. 4, 22-25 The rapid detection 
of these ischemic events is important, since an 
aggressive response to such events is necessary to 
prevent reinfarction.26 
Because of the sometimes transient nature of cor- 
QRS monitoring for vessel patency in AMI 947 
onary perfusion,27 the rapid development of coronary 
reocclusion, and the frequency of recurrent ischemia, 
an ideal method for monitoring patients with acute 
myocardial infarction should be safe, accurate, and 
reproducible and should present the results on-line 
for real-time analysis. At present only ECG monitor- 
ing with ST segment and/or QRS complex analysis 
seem to fulfill these demands. Although the capabil- 
ity of continuous vectorcardiography in detecting re- 
current ischemia is beyond the scope of the present 
report, Fig. 5 illustrates the immediate changes 
occurring on the QRS/ST trend curves when is- 
chemia recurs. Since the monitoring system has full 
on-line capacity, the changes can truly be observed in 
real-time. We believe that QRS complex and ST seg- 
ment monitoring with continuous on-line vectorcar- 
diography has substantial potential for monitoring of 
patients with acute myocardial infarction. The 
present results are based on a limited number of pa- 
tients and the present data should be regarded as 
preliminary. Continuous on-line vectorcardiography 
is presently the subject of further study in this field. 
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